- Raised $3.5M funding round, Feb 2019
About
Epeius Pharma is a cell and gene therapy company developing biological vehicles for the delivery of therapeutic proteins into the central nervous system. Epeius Pharma's platform could allow for an effective and scalable strategy for disease medication in neurodevelopmental and neurological pathologies that could benefit from direct neuron protein replacement treatments. Its first target indication will be Rett syndrome. Epeius Pharma was founded based on the joint research efforts of Professor Oded Rechavi and Shahar Bracha of the Department of Neurobiology, Wise Faculty of Life Sciences & Sagol School of Neuroscience, Tel Aviv University, and Dr. Lilach Sheiner, senior lecturer and research fellow at the Wellcome Center of Integrative Parasitology, University of Glasgow. It was licensed from Ramot, the technology transfer company of Tel Aviv University and Glasgow University.
Funding history · 1 round · $3.5M total
Q&A
- What is Epeius Pharma's primary focus?
- Epeius Pharma is a cell and gene therapy company focused on developing biological vehicles for the delivery of therapeutic proteins into the central nervous system.
- When was Epeius Pharma founded?
- Epeius Pharma was founded in February 2019.
- What is Epeius Pharma's first target indication?
- Epeius Pharma's first target indication for its platform is Rett syndrome.
- How much funding has Epeius Pharma raised to date?
- Epeius Pharma has raised a total of $3,500,000.
- Which investors participated in Epeius Pharma's funding round?
- RMGP Biopharma Investment Fund and FutuRx participated in Epeius Pharma's funding round in February 2019.
- What is the current employee count for Epeius Pharma?
- Epeius Pharma has an employee count in the 1-10 range.
- From which institutions was Epeius Pharma's technology licensed?
- Epeius Pharma's technology was licensed from Ramot, the technology transfer company of Tel Aviv University, and Glasgow University.
- What is Epeius Pharma's current product stage?
- Epeius Pharma's current product stage is research and development (R&D).
Team · 2
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | futurx.co.il/cgi-sys/suspendedpage.cgi |
|---|---|
| linkedin.com/company/77039352 |
Identifiers & details
| Founded | 2019-2 |
|---|---|
| Employees (exact) | 4 |
Radar intelligence
Web history (Wayback)
| Domain | futurx.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 10 |
|---|